The research reveals how targeting the KMT2D gene could help correct oral disorders and prevent craniofacial birth defects.

The downsides of diagnosis and an epic trek following a Slovenian wolf are among our culture editor's top popular science ...

GAMMA Investing LLC boosted its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 13.7% ...

For patients with multiple myeloma, the use of novel agents in first-line triplet and quadruplet induction regimens -- with ...

Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...

When it comes to treating autoimmune diseases, recognizing the symptoms early is key. Maybe you first heard about an ...